Skip to main content
SpringerLink
Log in

Imiquimod

A Viewpoint by Stephen Shumack

  • Adis Drug Profile
  • Guest Commentaries
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ahmed I, Berth-Jones J. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol. 2000 Oct; 143 (4): 843–5

    Article  PubMed  CAS  Google Scholar 

  2. Didona B, Benucci R, Amerio P, et al. Primary cutaneous CD30 & T cell lymphoma responsive to topical imiquimod (Aldara)TM. Br J Dermatol. 2004 Jun; 150 (6): 1198–201

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Royal North Shore Hospital, Sydney, Australia

    Stephen Shumack

Authors
  1. Stephen Shumack
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shumack, S. Imiquimod. Am J Clin Dermatol 6, 201 (2005). https://doi.org/10.2165/00128071-200506030-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200506030-00007

Keywords

Search

Navigation